Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Net Margin (2025)

Updated

Avenue Therapeutics' Net Margin was -207.19% in FY2025.

Analysis

Avenue Therapeutics (ATXI) Net Margin (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 0.83%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 21.27%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -8.04%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 22.65%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 16.30%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 23.62%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -134.51%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -1.65%
10 Avenue Therapeutics 1.27 Mn -9.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 23.86%
API Access

Avenue Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ATXI&period=max&api_key=YOUR_API_KEY